Ovarian Adenocarcinoma
Patient Internal ID: 1591653811
C56 Malignant Neoplasm of Ovary
September 2017
Recurrent Ovarian Adenocarcinoma, High Grade, Platinum Resistant BRCA Wild Type. Disease progression in April 2019, April 2021- Mass in Pelvic area.
Chemotherapy (Carboplatin, Paclitaxel, Avastin), Surgery, Chemotherapy (Carboplatin, Paclitaxel, Avastin), Chemotherapy (Carboplatin & Liposomal Doxorubicin), Target Therapy (Niraparib), Chemotherapy (Carboplatin/ Gemcitabine), Chemotherapy (Carboplatin).
The prognosis remains poor. The average relative 5-year survival rate for those diagnosed with Distant Spread Ovarian Cancer is about 31%. The median survival of Metastatic Ovarian Cancer is 24.7 months (Swedish Cancer Registry).
Allogeneic Umbilical Cord Blood Derived NK Cells (4 doses) with Interleukin-2 over a period of 1 month. Additionally, the patient received Neoantigen Vaccines with Specific Peptides (10 doses).
The patient has survived for 6,5 years since the diagnosis and 46 months since disease progression. At the time of review, disease progression had been detected. It can be concluded that the addition of Immunotherapy, alongside Surgery, Chemotherapy, and Target Therapy, has extended patient survival by an estimate of around 21 months so far.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-advertisement | session | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category . |
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
CookieLawInfoConsent | 1 year | Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie. |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.